Lobbying Disclosure Report – Endo Pharmaceuticals (2013) — Issue Type =
Outcome: Successfully Withdrawn. The company is now providing some of the highest level of lobbying spending transparency in the pharmaceutical industry.

Recent Comments

    BCorp_logo_transparent
    loggo
    PRI-Sig-Web-V1
    60c786462eca4767cdb5f850_5ed50aabb6d6d8168afd5fc2_ussif_memberlogo_2017_72dpi
    62067026a1b3b6333377da54_American Sustainable Business Network Logo
    60df13624c0183ae5d74f1c4_Eurosif_Blue
    60df13624c01830e4674f1c3_VBDO_Blue
    60df13624c01836f6b74f1c5_UKSIF_blue
    Boston

    Two Financial Center
    60 South Street, Suite 1100
    Boston, MA 02111
    ‍
    (800) 548-5684
    (617) 423-6655

    trillium-primary-logo
    Active Portfolios, Global Impact: Putting Assets into Action since 1982®
    By clicking the links to third party sites you are leaving the Trillium site and entering a third party site. Trillium are not responsible for any information contained on the third party site.

    Hit enter to search or ESC to close